Imatinib: Targeted Cancer Therapy Drug

Chronic Myeloid Leukemia (CML) : Especially in patients with the Philadelphia chromosome (Ph+)
Gastrointestinal Stromal Tumors (GIST) : With mutations in the c-KIT gene
Other blood cancers as determined by oncologists

Mechanism of action of Imatinib

Imatinib is a Tyrosine Kinase Inhibitor (TKI) drug that works by inhibiting the enzyme tyrosine kinase that is involved in the growth of cancer cells, causing

Stop cancer cell division
Reduce the number of abnormal cells
Long-term disease control

Advantages of using Imatinib

It is a drug that acts specifically on cancer cells.
It has fewer side effects than chemotherapy drugs.
It helps extend the life of patients and control the disease well.
There is research supporting it both in Thailand and abroad.

Side effects that may be experienced

Although it is safer than chemotherapy, Imatinib can have side effects, such as:

Swelling around eyes, hands, or feet
Nausea, stomach pain
Skin rash, dry skin
Liver function abnormalities (requires monitoring)

Now available at a lower cost in Thailand

Originally, Imatinib had to be imported from abroad, which was quite expensive. However, it is now produced in Thailand, making it

Reduce treatment costs
Increase patient access to medicine
Promote quality treatment in the Thai public health system

Imatinib is an important targeted therapy for the treatment of certain types of cancer, particularly CML and GIST, and is more effective and has fewer side effects than conventional chemotherapy. If used properly under the supervision of a specialist, it can help extend the patient's life and improve their quality of life significantly.

If you or someone close to you has been diagnosed with any of the above-mentioned cancers, do not hesitate to consult an oncologist to plan an appropriate treatment regimen.